Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PB) Other Operating Expenses (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Other Operating Expenses for 13 consecutive years, with $20.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 12.81% year-over-year to $20.7 million, compared with a TTM value of $79.4 million through Dec 2025, up 8.71%, and an annual FY2025 reading of $79.4 million, up 8.95% over the prior year.
  • Other Operating Expenses was $20.7 million for Q4 2025 at Global Medical REIT, up from $20.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $20.7 million in Q4 2025 and bottomed at $11.5 million in Q2 2021.
  • Average Other Operating Expenses over 5 years is $17.2 million, with a median of $18.3 million recorded in 2024.
  • Peak annual rise in Other Operating Expenses hit 979.92% in 2021, while the deepest fall reached 48.76% in 2021.
  • Year by year, Other Operating Expenses stood at $12.9 million in 2021, then surged by 52.35% to $19.7 million in 2022, then fell by 13.17% to $17.1 million in 2023, then rose by 7.28% to $18.4 million in 2024, then grew by 12.81% to $20.7 million in 2025.
  • Business Quant data shows Other Operating Expenses for GMRE-PB at $20.7 million in Q4 2025, $20.2 million in Q3 2025, and $20.2 million in Q2 2025.